Bausch Health Companies (BHC) Gains from Investment Securities (2009 - 2026)

Bausch Health Companies has disclosed Gains from Investment Securities across 18 years of filings, most recently posting $34.0 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $34.0 million, up 112.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.0 million (up 50.0% YoY), and the FY2025 annual result was $24.0 million, down 7.69% from the prior year.
• Gains from Investment Securities came in at $34.0 million for Q1 2026 at Bausch Health Companies, up from $5.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $34.0 million in Q3 2022 to a low of -$29.0 million in Q2 2022.
• The 5-year median for Gains from Investment Securities is $5.0 million (2024), against an average of $8.7 million.
• Peak annual rise in Gains from Investment Securities reached 1033.33% in 2022, while the deepest fall reached 207.41% in 2022.
• Bausch Health Companies' Gains from Investment Securities stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then soared by 200.0% to $3.0 million in 2024, then jumped by 66.67% to $5.0 million in 2025, then jumped by 580.0% to $34.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $34.0 million (Q1 2026), $5.0 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.